FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2024
Back to search
Official data from USPTO
MEDINOXX MODULAR MEDICATION SYSTEMS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/06/2024
Trademark type
Combined
Nice classes
7, 10, 16, 21
Filing date
03/07/2022
Registration date
03/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/05/2024
Last transaction
03/05/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
AT
Examiner
COWARD, JEFFERY
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design comprised of seven red rectangles of various sizes over the blue wording "MEDINOXX" over the red wording "MODULAR MEDICATION SYSTEMS".
Holders and representatives
Holders
Medinoxx GmbH
Representatives
Paul G. Johnson Maschoff Brennan
Technical classification
Nice Classes
Class 7Class 10Class 16Class 21
Vienna Codes
No Vienna codes available.
Goods and services
Class 7
Machines for dispensing medicationdrugspharmaceuticals during the packaging process for industrial use; machines for packaging medicationdrugspharmaceuticals
Class 10
Medical apparatus for drug administrationdosage dispensers for administering and dispensing medicationdrugspharmaceuticals to patients; cups for administering medicine
Class 16
Bags of paper or plastic for wrapping and packaging
Class 21
Pill boxes for personal use
Publications
History of USPTO decisions and trademark events.
26 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2023
PUBO
PUBLISHED FOR OPPOSITION
12/19/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/13/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
11/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
11/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/11/2023
RFNT
REFUSAL PROCESSED BY IB
03/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/15/2023
RFRR
REFUSAL PROCESSED BY MPU
02/15/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/20/2022
CNRT
NON-FINAL ACTION WRITTEN
12/19/2022
DOCK
ASSIGNED TO EXAMINER
12/17/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/20/2022
Continuous trademark protection
Get notified about every new filing that threatens MEDINOXX MODULAR MEDICATION SYSTEMS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.